8247.HK - Biosino Bio-Technology and Science Incorporation

HKSE - HKSE Delayed Price. Currency in HKD

Biosino Bio-Technology and Science Incorporation

No. 27, Chaoqian Road
Science and Technology Industrial Park Changping District
Beijing 102200
86 10 6972 2840

IndustryDiagnostics & Research
Full Time Employees490

Key Executives

NameTitlePayExercisedYear Born
Prof. Lebin WuChairman, Compliance Officer and Director of Baiao Pharmaceuticals170.89kN/A1962
Mr. Chen JintianVice-Chairman, Chief Exec. Officer and Pres101.71kN/A1978
Dr. Cunmao XuVP, Sec. and Exec. Director104.88kN/A1963
Mr. Woon Cheung Tung CPA, CPA, (U.S)Company Sec.N/AN/A1971
Ms. Ping YaoVPN/AN/A1962
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.


Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagent products primarily in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; analyzers, such as flow cytometers and clinical chemistry analyzers; Elisa kits; and rapid tests. It also provides medical and medical inspection services; produces medical instruments; distributes immunodiagnostic products; and offers investment management services, as well as consulting services related to non-securities business and equity investment management. The company also exports its products to approximately 40 countries in Asia, Africa, and East Europe. Biosino Bio-Technology and Science Incorporation was founded in 1988 and is based in Beijing, the People's Republic of China.

Corporate Governance

Biosino Bio-Technology and Science Incorporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.